Jane Street’s BioTelemetry, Inc. BEAT Stock Holding History

Jane Street’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28,429	Closed	-$2.05M	–	10014
2020 Q4	$2.05M	Sell	28,429 -3,112	-10%	-$163K	﹤0.01%	3440
2020 Q3	$1.44M	Buy	+31,541	New	+$1.32M	﹤0.01%	3530
2020 Q1	–	Sell	-8,858	Closed	-$408K	–	6430
2019 Q4	$410K	Buy	+8,858	New	+$384K	﹤0.01%	3922
2019 Q3	–	Sell	-16,825	Closed	-$810K	–	6198
2019 Q2	$810K	Buy	16,825 +8,543	+103%	+$449K	﹤0.01%	2975
2019 Q1	$518K	Buy	8,282 +891	+12%	+$61.2K	﹤0.01%	3644
2018 Q4	$441K	Buy	+7,391	New	+$444K	﹤0.01%	3600
2014 Q3	–	Sell	-38,569	Closed	-$277K	–	3542
2014 Q2	$277K	Sell	38,569 -16,724	-30%	-$133K	﹤0.01%	1907
2014 Q1	$558K	Buy	55,293 +44,532	+414%	+$410K	0.01%	1467
2013 Q4	$85K	Sell	10,761 -44,552	-81%	-$416K	﹤0.01%	2202
2013 Q3	$548K	Sell	55,313 -85,717	-61%	-$675K	0.01%	1628
2013 Q2	$832K	Buy	+141,030	New	+$475K	0.01%	1041

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Jane Street's BEAT Position: Q1 2021 in Review

Jane Street sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 28,429 shares — an estimated $2.05M sold.

Jane Street first reported a position in BEAT in Q2 2013 and held it in 11 quarters. The position peaked at $2.05M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Jane Street reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Jane Street sold 28,429 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.05M.
Jane Street first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 11 quarters.
Jane Street's BioTelemetry, Inc. position peaked at $2.05M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.